Baupost Group Raises Stake in PDL BioPharma, Inc. (PDLI) to 10.53%

In a 13G filing on PDL BioPharma, Inc. (NASDAQ: PDLI), hedge fund Baupost Group disclosed a 10.53%, or 14,718,814 share, stake in the company. This is up 40.24% from the 10,495,225 shares held at the end of the latest quarter ending March 31, 2011.

For more notable holders of PDL BioPharma, Inc. stock click here. For more information on Baupost Group click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• HP Inc. (HPQ) Climbs Following Stake by Greenlight Capital
• Jana, in Letter, Urges Wolfspeed (WOLF) to Eye Sale, Other Strategic Alternatives - Reuters
• GoPro (GPRO) Mentioned in Tweet Citron Research